"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Biocon Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Kiran Mazumdar Shaw
Home : Indian Private	Book Value: 119.5408865
BSE Code : 532523	Market Cap: 52515.93
NSE Code : BIOCON	P / E : 0

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	583.30	537.10	643.80	562.80
Other Income	133.80	61.30	62.70	671.70
Total Income	717.10	598.40	706.50	1234.50
Total Expenditure	530.40	516.50	581.80	531.50
Operating Profit	186.70	81.90	124.70	703.00
Interest	67.20	56.20	56.70	65.30
Gross Profit	119.50	25.70	68.00	637.70
Depreciation	33.80	33.30	33.00	33.80
Tax	3.20	1.10	26.50	8.40
Deferred Tax	11.60	-0.40	-12.70	11.50
Reported Profit After Tax	70.90	-8.30	21.20	584.00

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView